6421 - 6430 of 7916 Results
Title
Year
-
RESTRICTEDTitle: LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?Journal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 3Start Page: 214End Page: 225Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1570159x13666151030102847Best OA location URL: https://europepmc.org/articles/pmc4857626?pdf=renderCitation Count: 66
-
RESTRICTEDTitle: Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinsons DiseaseJournal Name: Current NeuropharmacologyPublisher: Bentham Science Publishers Ltd.Vol: 14Issue #: 3Start Page: 238End Page: 249Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1570159x13666151030103027Best OA location URL: https://europepmc.org/articles/pmc4857622?pdf=renderCitation Count: 54
-
OPENTitle: mGlu5positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndromeJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 25Issue #: 10Start Page: 1990End Page: 2004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/hmg/ddw074Best OA location URL: https://academic.oup.com/hmg/article-pdf/25/10/1990/18527444/ddw074.pdfCitation Count: 52
-
RESTRICTEDTitle: A suggested minimum standard deep brain stimulation evaluation for essential tremorJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 362Issue #:Start Page: 165End Page: 168Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2016.01.041Citation Count: 6
-
OPENTitle: Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in ratsJournal Name: NeurosciencePublisher: Elsevier BVVol: 318Issue #:Start Page: 157End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2016.01.020Best OA location URL: https://europepmc.org/articles/pmc4753102?pdf=renderCitation Count: 83
-
OPENTitle: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysisJournal Name: Carbohydrate ResearchPublisher: Elsevier BVVol: 422Issue #:Start Page: 1End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008Best OA location URL: http://manuscript.elsevier.com/S0008621515003997/pdf/S0008621515003997.pdfCitation Count: 17
-
RESTRICTEDTitle: Vocal tics in Tourette's syndromeJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 15Issue #: 3Start Page: e1End Page: e1Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)00021-1Citation Count: 4
-
OPENTitle: 4-amino-7-chloroquinoline derivatives for treating Parkinson’s disease: implications for drug discoveryJournal Name: Expert Opinion on Drug DiscoveryPublisher: Informa HealthcareVol: 11Issue #: 4Start Page: 337End Page: 341Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1517/17460441.2016.1154529Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1517/17460441.2016.1154529?needAccess=trueCitation Count: 18
-
OPENTitle: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid HydroxylaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 59Issue #: 6Start Page: 2579End Page: 2595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780Best OA location URL: https://europepmc.org/articles/pmc4836378?pdf=renderCitation Count: 13
- Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriers2016RESTRICTEDTitle: Increased peripheral inflammation in asymptomatic leucine‐rich repeat kinase 2 mutation carriersJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 6Start Page: 889End Page: 897Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26529Citation Count: 72